Abstract:Among the many new diseases which have been described during the present century, there are a remarkable number of disea §es of the osseous system. In some instances this is due to the necessity of x-ray examination and biochemical investigation for their diagnosis, but in others, such as osteopetrosis (Albers-Schonberg disease), osteochondrodystrophy (Morquio's disease), gargoylism (dysostosis multiplex), and hypertelorism, these aids were not essential, and it is perhaps surprising that the conditions escape… Show more
“…If EPF is associated with anomalies of the cerebral vasculature, additional vascular imaging like CT, MR, or digital subtraction angiography might be warranted [21]. In young children, EPF may present as a single aperture of the parietal bone, referred to as cranium bifidum as mentioned above [7,25]. EPF is caused by a heterozygous mutation in the homeobox genes ALX4 and MSX2 located at 5q34-35 and 11p11, respectively [6].…”
Section: Diagnosismentioning
confidence: 99%
“…Enlarged parietal foramina (EPF) are variable intramembranous ossification defects of the parietal bones and were first described in 1707, and received little attention until the 1940s [7,14] (Figs. 1-3, 4, and 5).…”
Section: Introductionmentioning
confidence: 99%
“…These are considered normal common variants of the parietal bones, allow for passage of emissary veins, and occur in about 60-70 % of the population [17,21] and are believed to have no correlation with instances of small parietal foramina, and in one study there has been evidence of individuals with both small parietal foramina and enlarged at the same time [4,23]. The hereditary nature of EPF and associated genes have been characterized [7]. In young children, this condition may present as a persistently enlarged posterior fontanelle caused by a single large central parietal bone defect, termed cranium bifidum [25].…”
Introduction Enlarged parietal foramina are variable ossification defects in the parietal bones that present as symmetric radiolucencies on skull radiographs. In contrast to the normal small parietal foramina, enlarged parietal foramina are a hereditary condition and genes associated with it have been identified. Methods A literature review was performed to discuss the many known findings related to enlarged parietal foramina. Conclusions Even though they remain asymptomatic in the majority of cases, they may be associated with other pathologies and occasionally become symptomatic. This article provides a comprehensive review of the current knowledge of enlarged parietal foramina.
“…If EPF is associated with anomalies of the cerebral vasculature, additional vascular imaging like CT, MR, or digital subtraction angiography might be warranted [21]. In young children, EPF may present as a single aperture of the parietal bone, referred to as cranium bifidum as mentioned above [7,25]. EPF is caused by a heterozygous mutation in the homeobox genes ALX4 and MSX2 located at 5q34-35 and 11p11, respectively [6].…”
Section: Diagnosismentioning
confidence: 99%
“…Enlarged parietal foramina (EPF) are variable intramembranous ossification defects of the parietal bones and were first described in 1707, and received little attention until the 1940s [7,14] (Figs. 1-3, 4, and 5).…”
Section: Introductionmentioning
confidence: 99%
“…These are considered normal common variants of the parietal bones, allow for passage of emissary veins, and occur in about 60-70 % of the population [17,21] and are believed to have no correlation with instances of small parietal foramina, and in one study there has been evidence of individuals with both small parietal foramina and enlarged at the same time [4,23]. The hereditary nature of EPF and associated genes have been characterized [7]. In young children, this condition may present as a persistently enlarged posterior fontanelle caused by a single large central parietal bone defect, termed cranium bifidum [25].…”
Introduction Enlarged parietal foramina are variable ossification defects in the parietal bones that present as symmetric radiolucencies on skull radiographs. In contrast to the normal small parietal foramina, enlarged parietal foramina are a hereditary condition and genes associated with it have been identified. Methods A literature review was performed to discuss the many known findings related to enlarged parietal foramina. Conclusions Even though they remain asymptomatic in the majority of cases, they may be associated with other pathologies and occasionally become symptomatic. This article provides a comprehensive review of the current knowledge of enlarged parietal foramina.
“…Enlarged parietal foramina (EPFs) are variable intramembranous ossification defects of the parietal bones, first described in 1707, and which have received little attention until the 1940s. 1,2 In normal fetuses, the frontal, parietal, and squamous parts of the temporal bones undergo intramembranous ossification, a direct ossification of the vascularized membrane. Broca, in 1875, 3,4 had already pointed out an unusual enlargement of the parietal foramina due to a failure in the development of the parietal bones.…”
Introduction The enlarged parietal foramen (EPF) is a defect in the ossification of the parietal bone that is well described in the literature using a variety of nomenclatures. Individuals with EPF can present symptoms such as migraines, vomiting and intense pain when light pressure is applied to the skull. However, it can go unnoticed for a lifetime.
Materials and Methods At the Human Bone Collection department of the Universidade Federal de Pernambuco, 2 craniums (CAV 90, 96 years old and CAV 16, 81 years old) and were identified as having EPF, both from females.
Results There was no apparent kinship between both craniums. The sagittal length, the coronal width, the sagittal suture distance, the coronal suture distance and the lambdoid suture distance of each enlarged parietal foramen were evaluated, with the following results: sagittal length: 5.5 cm (CAV 90), and 5.0 cm (CAV 16); coronal width: 3.1 cm (CAV 90),and 3.4 cm (CAV 16); sagittal suture distance: 2.9 cm (CAV 90), and 2.3 cm (CAV 16); coronal suture distance: 1.8 cm (CAV 90), and 4.6 cm (CAV 16); and lambdoid suture distance: 5.0 cm (CAV 90), and 3.0 cm (CAV 16). The parietal foramen of both craniums exhibited equivalent measurements.
Conclusion Due to the low incidence of EPF, the identification of the 2 craniums with this condition in a collection of 105 skeletons makes the discovery relevant. In reference to craniums exhibiting EPF, this is an important tool for study and forensic research, since its appearance is linked to heredity.
“…Goldsmith described 5 generations of the Catlin family with enlarged parietal foramina [7]. Transmission is autosomal dominant with incomplete penetrance; responsible genes have been identified [4,10,21].…”
Here we present a case of a 2-month-old child with an atretic encephalocele and large persistent parietal foramina. The course was unusual in that the parietal foramina significantly increased in size over a relatively short time.
At the age of three months the child required surgery because of the increasing skull defect. During surgery the cause of the growing skull defect was revealed as a medial atretic encephalocele with enlarged parietal foramina.
Large parietal foramina are a rare clinical entity with a prevalence ranging from 1:15.000 to 1:25.000. The skull defect is usually identified on physical examination and confirmed radio graphically.
We assume that the mechanism underlying the growing bone defect is identical to that of a growing skull fracture. To our knowledge this is the only reported case of an infant with a growing skull defect requiring surgery due to an atretic encephalocele protruding through a growing parietal foramina.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.